<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">76223</article-id><article-id pub-id-type="doi">10.7554/eLife.76223</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Distinct impact of IgG subclass on autoantibody pathogenicity in different IgG4-mediated diseases</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-218471"><name><surname>Bi</surname><given-names>Yanxia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-218472"><name><surname>Su</surname><given-names>Jian</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218473"><name><surname>Zhou</surname><given-names>Shengru</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218474"><name><surname>Zhao</surname><given-names>Yingjie</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218475"><name><surname>Zhang</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-218476"><name><surname>Zhang</surname><given-names>Huihui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-218477"><name><surname>Liu</surname><given-names>Mingdong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218478"><name><surname>Zhou</surname><given-names>Aiwu</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-263848"><name><surname>Xu</surname><given-names>Jianrong</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-218479"><name><surname>Pan</surname><given-names>Meng</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-218480"><name><surname>Zhao</surname><given-names>Yiming</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-214726"><name><surname>Li</surname><given-names>Fubin</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6268-3378</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf5"/></contrib><aff id="aff1"><institution content-type="dept">Shanghai Institute of Immunology</institution>, <institution>Shanghai Jiao Tong University</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><aff id="aff2"><institution content-type="dept">Jiangsu Institute of Hematology</institution>, <institution>First Affiliated Hospital of Soochow University</institution>, <addr-line><named-content content-type="city">Suzhou</named-content></addr-line>, <country>China</country></aff><aff id="aff3"><institution content-type="dept">Department of Dermatology</institution>, <institution>Shanghai Jiao Tong University</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><aff id="aff4"><institution content-type="dept">Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education</institution>, <institution>Shanghai Jiao Tong University</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-61967"><name><surname>Kurosaki</surname><given-names>Tomohiro</given-names></name><role>Reviewing editor</role><aff><institution>Osaka University</institution>, <country>Japan</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>pm10633@rjh.com.cn</email> (MP);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>zhaoyimingbox@163.com</email> (YZ);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>fubin.li@sjtu.edu.cn</email> (FL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>08</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e76223</elocation-id><history><date date-type="received"><day>08</day><month>12</month><year>2021</year></date><date date-type="accepted"><day>02</day><month>08</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Bi et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Bi et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-76223-v1.pdf"/><abstract><p>IgG4 is the least potent human IgG subclass for the FcγR-mediated antibody effector function. Paradoxically, IgG4 is also the dominant IgG subclass of pathogenic autoantibodies in IgG4-mediated diseases. Here we show that the IgG subclass and Fc-FcγR interaction have a distinct impact on the pathogenic function of autoantibodies in different IgG4-mediated diseases in mouse models. While IgG4 and its weak Fc-FcγR interaction have an ameliorative role in the pathogenicity of anti-ADAMTS13 autoantibodies isolated from thrombotic thrombocytopenic purpura (TTP) patients, they have an unexpected exacerbating effect on anti-Dsg1 autoantibody pathogenicity in pemphigus foliaceus (PF) models. Strikingly, a non-pathogenic anti-Dsg1 antibody variant optimized for FcγR-mediated effector function can attenuate the skin lesions induced by pathogenic anti-Dsg1 antibodies by promoting the clearance of dead keratinocytes. These studies suggest that IgG effector function contributes to the clearance of autoantibody-Ag complexes, which is harmful in TTP, but beneficial in PF and may provide new therapeutic opportunity.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31422020</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Fubin</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>31870924</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Fubin</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81873431</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Yiming</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Jiangsu Provincial Natural Science Foundation</institution></institution-wrap></funding-source><award-id>BK20181164.</award-id><principal-award-recipient><name><surname>Zhao</surname><given-names>Yiming</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Shanghai Sailing Program</institution></institution-wrap></funding-source><award-id>16YF1409700</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Yan</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Shanghai Municipal Natural Science Foundation project</institution></institution-wrap></funding-source><award-id>15ZR1436400</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Huihui</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution>Shanghai Young Oriental scholar program 2015</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Zhang</surname><given-names>Huihui</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution>Innovative research team of high-level local universities in Shanghai</institution></institution-wrap></funding-source><award-id>SSMU-2DCX20180100</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Yan</given-names></name><name><surname>Zhang</surname><given-names>Huihui</given-names></name><name><surname>Li</surname><given-names>Fubin</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Yanxia Bi, A patent application based on the study has been submitted (Chinese patent application number: 202011408005.X), and Fubin Li, Yanxia Bi, Yan Zhang, and Huihui Zhang are listed as inventors..</p></fn><fn fn-type="conflict" id="conf3"><p>Yan Zhang, A patent application based on the study has been submitted (Chinese patent application number: 202011408005.X), and Fubin Li, Yanxia Bi, Yan Zhang, and Huihui Zhang are listed as inventors..</p></fn><fn fn-type="conflict" id="conf4"><p>Huihui Zhang, A patent application based on the study has been submitted (Chinese patent application number: 202011408005.X), and Fubin Li, Yanxia Bi, Yan Zhang, and Huihui Zhang are listed as inventors..</p></fn><fn fn-type="conflict" id="conf5"><p>Fubin Li, A patent application based on the study has been submitted (Chinese patent application number: 202011408005.X), and Fubin Li, Yanxia Bi, Yan Zhang, and Huihui Zhang are listed as inventors..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All mice were bred and maintained under specific pathogen-free (SPF) conditions, and all animal experiments were performed under the institutional guidelines of the Shanghai Jiao Tong University School of Medicine Institutional Animal Care and Use Committee (Protocol Registry Number: A-2015-014).</p></fn><fn fn-type="other"><p>Human subjects: Ethical approval was obtained from the Ethics Committees in The Rui Jin Hospital of Shanghai Jiao Tong University School of Medicine and The First Affiliated Hospital of Soochow University, respectively. All PF and TTP patients and healthy volunteers signed informed consent.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data and materials generated or analyzed during this study are either included in this manuscript (Figures and supplementary information) or available upon reasonable request.</p></sec><supplementary-material><ext-link xlink:href="elife-76223-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>